apollo
0
48 Hrs returnable
COD available

Online payment accepted

Prescription drug

Whats That

tooltip
RAMUCIRUMAB-500MG
PARENTERAL
Not Returnable
Apr-24
Prescription drug
 Trailing icon

Country of origin

India
Other Info - CYR0011

FAQs

Cyramza 500 Injection 50 ml contains Ramucirumab, which works by inhibiting the abnormal growth of cancer cells and, finally, causes the initiation of programmed cell death.
Inform your doctor whether you have received any other cancer treatment. Cyramza 500 Injection 50 ml may cause reversible posterior leukoencephalopathy syndrome, arterial thromboembolic events, hypertension, infusion-related reactions, gastrointestinal perforation, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, lung problems, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Cyramza 500 Injection 50 ml.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Caution

It is unknown whether Cyramza 500 Injection 50 ml interacts with alcohol. Consult your doctor for more information.

bannner image

Pregnancy

Unsafe

Cyramza 500 Injection 50 ml is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Cyramza 500 Injection 50 ml. You should not become pregnant while you are receiving Cyramza 500 Injection 50 ml for at least three months from the last dose of Cyramza 500 Injection 50 ml. Using effective birth control methods while on treatment is suggested.

bannner image

Breast Feeding

Unsafe

Cyramza 500 Injection 50 ml should not be taken if you are breastfeeding as it passes into breast milk and may harm your infant. Avoid nursing your child while on treatment with this medicine and for at least two months from the last dose of medicine.

bannner image

Driving

Not applicable

Cyramza 500 Injection 50 ml will be administered to hospitalized patients. Driving is not recommended.

bannner image

Liver

Safe if prescribed

If you have a pre-existing or a history of liver disease, inform your doctor before receiving Cyramza 500 Injection 50 ml. Based on population PK analysis, no dose adjustment is advised for patients with mild liver impairment. Patients with Child-Pugh B or C cirrhosis who received single-agent Cyramza 500 Injection 50 ml reported clinical deterioration.

bannner image

Kidney

Safe if prescribed

Hence, if you have a pre-existing or a history of kidney disease, inform your doctor. Based on population PK analysis, no dose adjustment is advised for patients with kidney impairment.

bannner image

Children

Unsafe

Cyramza 500 Injection 50 ml is not recommended for use in children as the safety and efficacy are not established.

icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

About Cyramza 500 Injection 50 ml

Cyramza 500 Injection 50 ml is an anti-cancer medicine used alone or in combination with other combination medicines for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma, hepatocellular cancer, colorectal cancer, and non-small cell lung cancer. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.

Cyramza 500 Injection 50 ml contains Ramucirumab as an active ingredient, which belongs to the class of monoclonal antibodies. It works by inhibiting the abnormal growth of cancer cells and, finally, causes the initiation of programmed cell death.

Cyramza 500 Injection 50 ml may cause some side effects, such as abdominal pain, dry mouth, mouth sores, increased blood pressure, diarrhoea, fatigue, nausea, headache, nose bleeds, vomiting, tiredness, and injection site reactions. If the side effects persist or bother you, please consult your doctor. Cyramza 500 Injection 50 ml will be administered by a doctor experienced in the administration of cancer medicine. Do not self-administer.

Avoid taking it and inform your doctor if you are allergic to Cyramza 500 Injection 50 ml or its components. Inform your doctor if you have any cardiovascular conditions, heart attack, stroke, increased blood pressure, any planned surgery, lung problems, or liver/kidney disease, as it can cause adverse effects. Cyramza 500 Injection 50 ml is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand.

Uses of Cyramza 500 Injection 50 ml

Colorectal Cancer, Stomach Cancer, Hepatocellular cancer, Non-small cell lung cancer.

Medicinal Benefits Mweb

Medicinal Benefits

Cyramza 500 Injection 50 ml contains Trastuzumab, which is used for treating patients with different types of cancer. This medicine works by inhibiting the excess production of a human vascular endothelial growth factor receptor 2, which is responsible for the growth and spread of cancer cells. This causes inhibition of the cancer cell growth and, finally, initiation of programmed cell death.

Directions for Use

A doctor who is trained or experienced in the administration of chemotherapeutic agents will administer Cyramza 500 Injection 50 ml. Do not self-administer.

Side Effects of Cyramza 500 Injection 50 ml

  • Nausea
  • Vomiting
  • Diarrhoea
  • Nose bleeds
  • Headache
  • Fatigue
  • Injection site reactions
  • Pain at the site of injection
  • Increased blood pressure
  • Dry mouth
  • Mouth sores
  • Fever
  • Back pain

Drug Warnings

Cyramza 500 Injection 50 ml should be avoided if you are allergic to it or any other components of this medicine. Before taking Cyramza 500 Injection 50 ml, inform your doctor if you have any history of cardiovascular conditions, heart attack, stroke, increased blood pressure, any planned surgery, lung problems, or liver or kidney disease, as it can cause adverse effects. Cyramza 500 Injection 50 ml may cause Cyramza 500 Injection 50 ml may cause reversible posterior leukoencephalopathy syndrome, arterial thromboembolic events, hypertension, an increased risk of hemorrhage, infusion-related reactions, gastrointestinal perforation, and clinical deterioration in patients with cirrhosis during the treatment. Hence, careful observation should be performed for any reactions in the patient. Cyramza 500 Injection 50 ml may cause embryo-fetal toxicity. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Breastfeeding should be discontinued in nursing mothers during the treatment. Cyramza 500 Injection 50 ml is not recommended for use in children as the safety and efficacy are not established.

Drug-Drug Interactions

verifiedApollotooltip
RamucirumabDabigatran etexilate
Severe
RamucirumabPiroxicam
Severe

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Diseases Interactions

verifiedApollotooltip
No Drug - Disease interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Drug Interactions Checker List

  • ATAZANAVIR
  • NATALIZUMAB
  • ETANERCEPT

Habit Forming

No

Special Advise

  • Avoid intercourse while on treatment with Cyramza 500 Injection 50 ml.
  • Regular, complete blood count monitoring is advised during the treatment.
  • Liver function tests (LFT) and kidney function tests (RFT) should be performed before starting the treatment and every 4 to 6 weeks during the treatment.
  • Regular ECG, blood pressure, and electrolytes should be monitored while taking the medicine.

Diet & Lifestyle Advise

  • Meditation and yoga have been proven very effective in helping cancer patients maintain a healthy attitude and body.
  • Eat more lean meats, healthy fats, fruits, vegetables, and whole-grain foods to give you more energy. 
  • Stay hydrated by drinking plenty of water, as dehydration is often seen in cancers.
  • Taking a stroll in the garden or spending 30 minutes of your time doing some light physical activity can be very useful. However, do not over-exert yourself if you feel too tired. 
  • Avoid smoking and alcohol consumption.

Add to Cart